Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Berk

Showing results (111-120 of 1,305) with videos related to

Pageof 131
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 7, 2021
Translational evidence for the Inflammatory Response System (IRS)/Compensatory Immune Response System (CIRS) and neuroprogression theory of major depressionMonojit Debnath, Michael Berk, Michael Maes
The Medical Journal of Australia|March 22, 2021
The evolution of clinical trials in response to COVID-19Alana Sarah, Olivia Dean, Michael Berk
Psychiatric Services (Washington, D.C.)|January 3, 2022
Hospital at Home and Associated Risks: In ReplyMatthew Towicz, Rachel Tindall, Michael Berk
Psychiatry and Clinical Neurosciences|May 18, 2005
The management of bipolar disorder in primary care: a review of existing and emerging therapiesMichael Berk, Seetal Dodd, Lesley Berk
Human Psychopharmacology|October 9, 2003
Trichotillomania: response to lithium in a person with comorbid bipolar disorderMichael Berk, Helen McKenzie, Seetal Dodd
Journal of Affective Disorders|May 31, 2011
Complementary medicine, self-help, and lifestyle interventions for obsessive compulsive disorder (OCD) and the OCD spectrum: a systematic reviewJerome Sarris, David Camfield, Michael Berk
Expert Review of Neurotherapeutics|July 13, 2006
Combination pharmacotherapy in unipolar depressionFelicity Ng, Seetal Dodd, Michael Berk
Current Drug Safety|April 22, 2010
Restless leg syndrome associated with olanzapine: a case seriesShilpa Aggarwal, Seetald Dodd, Michael Berk
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|May 9, 2013
N-acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trialAhmad Ghanizadeh, Nima Derakhshan, Michael Berk
The Australian and New Zealand Journal of Psychiatry|February 14, 2023
Can we overcome the heterogeneity of mood disorders in clinical trials?Aswin Ratheesh, Michael Berk, Lianne Schmaal
Pageof 131

Showing results (111-120 of 1,305) with videos related to

Sort By:
Pageof 131
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 7, 2021
Translational evidence for the Inflammatory Response System (IRS)/Compensatory Immune Response System (CIRS) and neuroprogression theory of major depressionMonojit Debnath, Michael Berk, Michael Maes
The Medical Journal of Australia|March 22, 2021
The evolution of clinical trials in response to COVID-19Alana Sarah, Olivia Dean, Michael Berk
Psychiatric Services (Washington, D.C.)|January 3, 2022
Hospital at Home and Associated Risks: In ReplyMatthew Towicz, Rachel Tindall, Michael Berk
Psychiatry and Clinical Neurosciences|May 18, 2005
The management of bipolar disorder in primary care: a review of existing and emerging therapiesMichael Berk, Seetal Dodd, Lesley Berk
Human Psychopharmacology|October 9, 2003
Trichotillomania: response to lithium in a person with comorbid bipolar disorderMichael Berk, Helen McKenzie, Seetal Dodd
Journal of Affective Disorders|May 31, 2011
Complementary medicine, self-help, and lifestyle interventions for obsessive compulsive disorder (OCD) and the OCD spectrum: a systematic reviewJerome Sarris, David Camfield, Michael Berk
Expert Review of Neurotherapeutics|July 13, 2006
Combination pharmacotherapy in unipolar depressionFelicity Ng, Seetal Dodd, Michael Berk
Current Drug Safety|April 22, 2010
Restless leg syndrome associated with olanzapine: a case seriesShilpa Aggarwal, Seetald Dodd, Michael Berk
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|May 9, 2013
N-acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trialAhmad Ghanizadeh, Nima Derakhshan, Michael Berk
The Australian and New Zealand Journal of Psychiatry|February 14, 2023
Can we overcome the heterogeneity of mood disorders in clinical trials?Aswin Ratheesh, Michael Berk, Lianne Schmaal
Pageof 131